Skip to content

Alliance of Infinity Trade

Cefoperazone + Sulbactam Vial Range.

Introducing AIT Pharmaceuticals Division’s Cefoperazone + Sulbactam Vial Range

At AIT Pharmaceuticals Division, we are committed to advancing healthcare by providing high-quality pharmaceutical products. Our Cefoperazone + Sulbactam Vial Range combines the potent antibacterial activity of cefoperazone with the beta-lactamase inhibitor sulbactam, offering a powerful solution for combating multidrug-resistant bacterial infections.

Drug Classification: Cefoperazone + Sulbactam is classified as a combination antibiotic. Cefoperazone belongs to the third-generation cephalosporin class, while sulbactam is a beta-lactamase inhibitor.

Category
Share

Formulations:

  • Cefoperazone + Sulbactam Vial: Available in strengths of 1gm and 2gm, our vials contain a sterile powder for reconstitution, providing flexibility in dosage administration.

Indications:

  • Our Cefoperazone + Sulbactam Vial is indicated for the treatment of:
    • Severe intra-abdominal infections
    • Respiratory tract infections, including pneumonia and bronchitis
    • Urinary tract infections
    • Skin and soft tissue infections
    • Septicemia and meningitis caused by susceptible organisms

Pharmacokinetics:

  • Absorption: Cefoperazone and sulbactam are administered parenterally and are rapidly absorbed after intravenous injection.
  • Distribution: Both drugs achieve high concentrations in various body tissues and fluids, including the lungs, kidneys, and cerebrospinal fluid.
  • Metabolism: Cefoperazone undergoes minimal metabolism in the liver, while sulbactam is primarily excreted unchanged in the urine.
  • Elimination: The elimination half-life of cefoperazone is approximately 1-2 hours, while sulbactam has a shorter half-life of about 0.5-1 hour.

Pharmacodynamics:

  • Cefoperazone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis and death.
  • Sulbactam acts as a beta-lactamase inhibitor, preventing the inactivation of cefoperazone by bacterial beta-lactamases and enhancing its antibacterial activity against beta-lactamase-producing strains.

Usage:

  • Our Cefoperazone + Sulbactam Vial is intended for intravenous administration by healthcare professionals trained in the proper handling and reconstitution of injectable medications.

Dosage:

  • The recommended dosage of Cefoperazone + Sulbactam varies depending on the type and severity of the infection, as well as the patient’s age, weight, and renal function.
  • Dosage adjustments may be necessary in patients with impaired renal function to prevent drug accumulation and toxicity.

Side Effects:

  • Common side effects of Cefoperazone + Sulbactam may include:
    • Nausea
    • Diarrhea
    • Injection site reactions
    • Hypersensitivity reactions, including rash and itching
  • Serious side effects such as anaphylaxis and pseudomembranous colitis may occur, although they are rare.

Experience the effectiveness and reliability of AIT Pharmaceuticals Division’s Cefoperazone + Sulbactam Vial Range in the treatment of severe bacterial infections. For more information, please contact us.

Reviews

There are no reviews yet.

Be the first to review “Cefoperazone + Sulbactam Vial Range.”

Your email address will not be published. Required fields are marked *